This site is intended for health professionals only
Thursday 25 April 2019
Share |

Insight e-Zine focuses on pharmaceutical industry

New edition focuses on the environmental, social and governance matters.

RepRisk has released the sixth edition of its Insight e-Zine, which focuses on environmental, social and governance (ESG) matters specific to the pharmaceutical industry.

Pharmaceutical companies hold a vast amount of power and, arguably, responsibility, due to the impact they have on people’s lives. The complexity of balancing this unique position with the necessity to maintain a profitable business has produced some interesting ethical challenges.

The corresponding ESG concerns are analysed and discussed in this issue of Insight from a range of corporate, NGO and academic perspectives.

The articles cover global issues such as the ethics of clinical trials in developing countries, misleading marketing of drugs, access to medicines, balancing profitability with patient protection, water security risks, anti-competition and bribery, and more.

Click here to read the e-Zine: RepRisk Insight #6

Ads by Google

You are leaving

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?


Respect for nurses: Sign up to our e-petition TODAY

The Nursing in Practice Respect campaign is now live! Over the coming months, we're set to highlight the vital contribution and efforts of primary care and community care nurses throughout the UK.

As part of our campaign, Nursing in Practice is looking to call on parliament to set up a debate to celebrate the vital work that you do.



Calling all primary care nurses! 'Like' our Nursing in Practice Facebook page to enter our free draw to win a £25 M&S voucher